Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis

BACKGROUND: Immune-related adverse events (irAEs) have been reported to be associated with the efficacy of immunotherapy. Herein, we conducted a meta-analysis to demonstrate that irAEs could predict the efficacy of immune checkpoint inhibitors (ICIs) in lung cancer patients. METHODS: Literature on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Donghui, Chen, Cen, Gu, Yanli, Lu, Wanjun, Zhan, Ping, Liu, Hongbing, Lv, Tangfeng, Song, Yong, Zhang, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958877/
https://www.ncbi.nlm.nih.gov/pubmed/33732650
http://dx.doi.org/10.3389/fonc.2021.631949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958877/
https://www.ncbi.nlm.nih.gov/pubmed/33732650
http://dx.doi.org/10.3389/fonc.2021.631949

Ejemplares similares